BioAegis Therapeutics LOGO 2.5 x 5 150 pixel.jpg
Study Identifies New Role of BioAegis’ ‘Inflammation Regulator’ Gelsolin Relevant for a Range of Inflammatory Diseases
April 08, 2021 18:58 ET | BioAegis Therapeutics
Gelsolin mitigates vascular damage by preventing release of IL-1β microparticles after trauma of high pressure and decompression.  Gelsolin is non-immunosuppressive unlike current treatments to quell...
Mouse lung intravital microscopy showing Lipopolysaccharide (LPS) induced inflammation
Arch Biopartners Releases New Video Showing Metablok Reducing Lung Inflammation in an Animal Model
March 31, 2020 07:36 ET | Arch Biopartners
TORONTO, March 31, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) a clinical stage company developing new drug candidates for treating...
Aphios Logo1.jpg
Aphios and LSU Health Shreveport Inventors Granted Patent to Improve Transplantation
June 19, 2018 08:00 ET | Aphios
WOBURN, Mass., June 19, 2018 (GLOBE NEWSWIRE) -- Aphios Corporation today announced that it and the LSU Health Shreveport Department of Molecular & Cellular Physiology have been granted United...